<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01945853</url>
  </required_header>
  <id_info>
    <org_study_id>NA_00080565</org_study_id>
    <nct_id>NCT01945853</nct_id>
  </id_info>
  <brief_title>Magnetic Resonance Imaging (MRI) in Amyotrophic Lateral Sclerosis (ALS)</brief_title>
  <official_title>Imaging Myelin Injury in Amyotrophic Lateral Sclerosis (ALS)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johns Hopkins University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Johns Hopkins University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a pilot study to identify the degree of grey and white matter involvement in patients
      with Amyotrophic Lateral Sclerosis (ALS) utilizing non-invasive techniques. The imaging to be
      utilized will be the 7 Tesla (7T) magnetic resonance imaging (MRI) of the brain. These
      results will be correlated to the ALS Functional Rating Scale - Revised (ALSFRS-R) score to
      assess if any changes in MRI can be predictive in the disability of the ALS patients at
      baseline and at 6 month intervals. The participants will be asked to return every 6 months
      for a neurological examination, ALSFRS-R assessment, measurement of the vital capacity and
      MRI as outlined above to monitor progression of the disease.
    </textblock>
  </brief_summary>
  <overall_status>Withdrawn</overall_status>
  <start_date>July 2013</start_date>
  <completion_date type="Actual">April 2015</completion_date>
  <primary_completion_date type="Actual">April 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>MRI Changes in ALS Patients Vs Healthy Controls</measure>
    <time_frame>2 years</time_frame>
    <description>Voxel Based Morphometry will be utilized to look for any changes in the MRI results comparing ALS subjects to healthy volunteers.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>MRI Changes in ALS Patients</measure>
    <time_frame>2 years</time_frame>
    <description>Voxel Based Morphometry will be utilized to look for any changes in the MRI results comparing ALS subjects comparing ALS subjects of differing clinical severity</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Amyotrophic Lateral Sclerosis (ALS)</condition>
  <arm_group>
    <arm_group_label>7 Tesla MRI</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>7T MRI will be done on ALS patients at baseline and at 6 month intervals.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>7 Tesla MRI</intervention_name>
    <arm_group_label>7 Tesla MRI</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Males and Females who are 18 - 80 years old.

          -  The participants will meet the standard diagnostic criteria for possible or probable
             ALS (based on El Escorial criteria). They will have been diagnosed by a Johns Hopkins
             Neurologist.

          -  Healthy controls will be recruited by their interest in assisting the ALS population.

        Exclusion Criteria:

          -  Forced vital capacity less than 60 % of predicted value.

          -  Documented orthopnea on ALSFRS-R or otherwise unable to lie flat in an MRI scanner for
             the duration of the study.

          -  Presence of pacemakers, aneurysm clips, shrapnel or otherwise disallowed implanted
             metallic devices for obtaining an MRI scan.

          -  Pregnant or lactating females

          -  Glomerular filtration rate (GFR) less than 60

          -  History of: encephalitis, extensive white matter disease, intracranial hemorrhage,
             cerebral palsy, allergy to dye and/or IV drug abuse.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jeffrey D Rothstein, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Johns Hopkins University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Johns Hopkins University</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21287</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 16, 2013</study_first_submitted>
  <study_first_submitted_qc>September 16, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 19, 2013</study_first_posted>
  <last_update_submitted>August 31, 2015</last_update_submitted>
  <last_update_submitted_qc>August 31, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 1, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Johns Hopkins University</investigator_affiliation>
    <investigator_full_name>Dr. Jeffrey Rothstein</investigator_full_name>
    <investigator_title>Professor of Neurology</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sclerosis</mesh_term>
    <mesh_term>Motor Neuron Disease</mesh_term>
    <mesh_term>Amyotrophic Lateral Sclerosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

